Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Thoracic Cancer|March 30, 2026
Tumor-Bearing Status Accelerates Bleomycin-Induced Pulmonary Inflammation via Endothelial ActivationShoko Isoyama, Kakuhiro Yamaguchi, Hiroshi Iwamoto, et al.
Case Reports in Oncology|February 10, 2021
Two Cases of Cranial Nerve Metastasis Treated with Radiotherapy and Chemotherapy in Patients with Lung AdenocarcinomaErika Kobayashi, Takeshi Masuda, Satoshi Nakao, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2017
[A Case of Central Diabetes Insipidus That Was Caused by Pituitary Metastasis of Lung Adenocarcinoma and Was Controlled by Radiation Therapy]Yusuke Izumi, Takeshi Masuda, Shinji Nabeshima, et al.
Plos One|June 4, 2021
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosisYu Nakanishi, Yasushi Horimasu, Kakuhiro Yamaguchi, et al.
Thoracic Cancer|September 29, 2021
Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive-stage small cell lung cancer: Two case reportsNaokazu Watari, Kakuhiro Yamaguchi, Takeshi Masuda, et al.
Anticancer Research|March 31, 2021
Autoantibody Positivity Is a Risk Factor for Chemotherapy-induced Exacerbation of Interstitial Pneumonia in Lung CancerNoriaki Ito, Takeshi Masuda, Taku Nakashima, et al.
The European Respiratory Journal|September 30, 2021
Accelerated decline in lung function in adults with a history of remitted childhood asthmaShinichiro Miura, Hiroshi Iwamoto, Keitaro Omori, et al.
Respiration; International Review of Thoracic Diseases|August 16, 2019
C-C Motif Chemokine Ligand 15 May Be a Useful Biomarker for Predicting the Prognosis of Patients with Chronic Hypersensitivity PneumonitisMasako Watanabe, Yasushi Horimasu, Hiroshi Iwamoto, et al.
Respiratory Research|November 11, 2024
Serum soluble isoform of receptor for advanced glycation end product is a predictive biomarker for acute exacerbation of idiopathic pulmonary fibrosis: a German and Japanese cohort studyErika Kitadai, Kakuhiro Yamaguchi, Shinichiro Ohshimo, et al.
Pulmonary Pharmacology & Therapeutics|February 11, 2021
Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort studyToshihito Otani, Kakuhiro Yamaguchi, Shinjiro Sakamoto, et al.
Pageof 12